ULTOMIRIS® (ravulizumab-cwvz) approved in the US for the treatment of adults with … – Morningstar

The most common side effects of ULTOMIRIS in people with NMOSD are COVID-19 infection, headache, back pain, urinary tract infection, and joint pain ( …
Source: back pain